大剂量氨溴索治疗急性呼吸窘迫综合征患者的临床效果分析

目的：研究大剂量氨溴索治疗急性呼吸窘迫综合征（ARDS）的临床效果，提高对该病防治水平。方法：选择本院80例急性呼吸窘迫综合征患者，随机分为对照组与干预组，对照组40例，给予抗生素、机械通气、激素、支持治疗等；干预组40例，在对照组基础上给予大剂量氨溴索治疗。结果：干预组与对照组治愈好转率分别为95．8％、60．5％，二者比较差异有统计学意义（P〈0．05）。两组患者住院时间、住院费用比较差异有统计学意义（P〈0．05）。结论：临床应用大剂量盐酸氨溴索可提高治愈率，改善预后，缩短住院时间，减少住院费用。

Analysis of Clinical Effect of Large Doses of Ambroxol in the Treatment of Acute Respiratory Distress Syndrome

Objective：To study the Clinical effects of large doses of ambroxol treatment of acute respiratory distress syndrome （ARDS） and improve the prevention and treatment of the disease.Method：Collected the clinical data of 80 cases of hospital patients with acute respiratory distress syndrome.They were randomly divided into two groups：control group （n=40）were given antibiotics, mechanical ventilation, hormone support therapy;intervention group of 40 patients were given large doses of ambroxol on the basis of the control group. Result：The intervention group and control group cure and improvement rate were 95.8%, 60.5%, the difference between the two groups was statistically significant（P〈0.05）, two groups of hospital stay, hospital costs difference was statistically significant（P〈0.05）.Conclusion：The clinical application of large doses of ambroxol hydrochloride can improve the cure rate, improve outcomes, shorten hospital stay, reduce hospital costs.